Amylyx Pharmaceuticals

AMLX

20.7505.17% ( +1.020 )

Closed: Jul 30, 16:00:00 (EDT)

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Amylyx Pharmaceuticals(AMLX) predict that the EBIT is -43.78 M (-15.81%), Miss estimate;the EPS is -0.37 (+11.9%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

Revenue

TBA--

0.00B--

----

EBITMiss expectations

-0.04B15.81%

-0.04B9.77%

-0.00B6.04%

EPSMiss expectations

-0.3711.90%

-0.355715.31%

-0.01433.41%

ActualEstimateUnit: USD

ActualEstimateUnit: USD

ActualEstimateUnit: USD

ActualEstimateUnit: USD